Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality
Interview with JoAnn E. Manson, MD, DrPH, author of Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - September 12, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
NAMS' New Hormone Therapy Position Statement: Clinical Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - August 15, 2017 Category: General Medicine Authors: Medscape Source Type: podcasts
NAMS' Hormone Therapy Statement: Primary Care Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - August 15, 2017 Category: OBGYN Authors: Medscape Source Type: podcasts
NAMS Clarifies HRT Options for Menopausal Symptoms
Dr Arefa Cassoobhoy highlights one of the week ' s important news stories for primary care. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - July 28, 2017 Category: General Medicine Authors: Medscape Source Type: podcasts
NAMS Clarifies HRT Options for Menopausal Symptoms
Dr Arefa Cassoobhoy highlights one of the week ' s important news stories for primary care. (Source: Medscape Internal Medicine Podcast)
Source: Medscape Internal Medicine Podcast - July 28, 2017 Category: Internal Medicine Authors: Medscape Source Type: podcasts
What to Know About the NAMS Updated Position on Hormone Therapy
Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - July 17, 2017 Category: General Medicine Authors: Medscape Source Type: podcasts
What to Know About the NAMS Updated Position on Hormone Therapy
Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - July 17, 2017 Category: OBGYN Authors: Medscape Source Type: podcasts
Longevity of Ovarian Function and Risk for Heart Failure
Dr Andrew Kaunitz discusses hormone receptor therapy in menopausal women and the relationship between ovarian function duration and risk for heart failure. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - June 8, 2017 Category: OBGYN Authors: Medscape Source Type: podcasts
Longevity of Ovarian Function and Risk for Heart Failure
Dr Andrew Kaunitz discusses hormone receptor therapy in menopausal women and the relationship between ovarian function duration and risk for heart failure. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - June 8, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
How Menopausal Hormone Therapy Could Reduce Alzheimer's Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the ' critical window ' hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Menopausal Hormone Therapy and Alzheimer Disease Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the ' critical window ' hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
How Menopausal Hormone Therapy Could Reduce Alzheimer's Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the ' critical window ' hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Podcast: Explaining menopause in killer whales, triggering killer mice, and the role of chromosome number in cancer immunotherapy
This week, we chat about a surprising reason why killer whales undergo menopause, flipping a kill switch in mice with lasers, and Fukushima residents who measured their own radiation exposure, with Online News Editor Catherine Matacic. Plus, Science ’s Alexa Billow talks to Stephen Elledge about the relationship between chromosomal abnormalities in tumors and immunotherapy for cancer.
Listen to previous podcasts.
[Image: Copyright Kenneth Balcomb Center for Whale Research; Music: Jeffrey Cook] (Source: Science Magazine Podcast)
Source: Science Magazine Podcast - January 19, 2017 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts
